Stock Update (NYSE:IBM): IBM Watson Health Companies Awarded Five Best in KLAS Designations

[PR Newswire] – CAMBRIDGE, Mass., Jan. 28, 2016 /PRNewswire/ — IBM Watson Health (NYSE: IBM ) today announced that the 2015/2016 Best in KLAS: Software & Services report recognized two of its newly acquired companies … Read more on this. International Business Machines Corporation (IBM) , valued at $117.93B, began trading this morning at $121.26. A quick look at the market, the company’s stock traded between $121.06 and $122.51 with a one year range of $118.00 to $176.30. IBM shares are currently priced at 8.96x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s 7.51x earnings multiple. And for dividend hunters, the company pays shareholders $5.20 per share annually in dividends, yielding 4.26%. In a review of the consensus earnings estimate this quarter, 19 sell-side analysts are looking at $2.08 per share, which would be $0.83 worse than the year-ago quarter and a $0.86 sequential decrease. What we find to be interesting is that the full-year EPS estimate of $13.50 is a $1.42 worse when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $18.24 Billion. If reported, that would be a 6.89% decrease over the year-ago quarter. More recently, JMP Securities Initiated IBM at Mkt Outperform (Nov 20, 2015). Previously, Cantor Fitzgerald Initiated IBM at to Hold. When considering if perhaps the stock is under or overvalued, the average price target is $132.15, which is 8.98% above where the stock opened this morning. See more in (NYSE:IBM) Similar Articles: Market Update (NYSE:IBM): Merge Healthcare and Greenway Health Collaborate to Automate the Medical Imaging Ordering Process for Health Care Providers Nationwide Stock Update (NYSE:IBM): IBM Watson Health details new HQ; announces new hires, partnerships Stock Update: International Business Machines Corporation (NYSE:IBM) – Watson supercomputer to benefit from IBM purchase of Merge Healthcare for $1 billion